Literature DB >> 3771749

Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome.

M Radetsky, R C Wheeler, M H Roe, J K Todd.   

Abstract

There is no ideal laboratory procedure or culture medium in current use for susceptibility testing of pathogenic yeasts. Six candidate growth media (RPMI 1640 with L-glutamine, yeast nitrogen base, Casamino Acids medium, Mueller-Hinton broth, Sabouraud dextrose broth, and minimum essential medium-Eagle salts) were screened by spectrophotometric absorbance for nucleic acid and protein. From these, two media were selected: a chemically defined growth medium (RPMI 1640 with L-glutamine) and a chemically complex medium (Casamino Acids). MICs of four antifungal agents (5-fluorocytosine, miconazole, ketoconazole, and amphotericin B) for 84 clinical isolates of various Candida species were then determined with both media in agar dilution and microtiter broth dilution systems. The resultant MICs were correlated with clinical outcome for those isolates obtained from patients treated with single antifungal agents, and susceptibility cut points were calculated. Derived MIC cut points for susceptibility were validated in a murine model of systemic candidiasis. RPMI 1640 with L-glutamine was found to have the lowest absorbance values for both nucleic acid and protein, while Casamino Acids medium was highest in both categories. We found that RPMI 1640 with L-glutamine was superior to Casamino Acids medium in the yield of MICs which correlated with actual clinical and animal outcome data. While there were no significant differences in MICs when RPMI 1640 medium was used, the microtiter broth dilution technique was superior to agar dilution in efficiency and ease of performance. We conclude that a microtiter broth system containing RPMI 1640 medium with L-glutamine is a simple, precise, and economical technique for susceptibility testing of pathogenic Candida species. We also suggest that the validation of susceptibility cut points with patient and animal outcome data make this microtiter broth system a preferential method for yeast susceptibility testing.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3771749      PMCID: PMC268979          DOI: 10.1128/jcm.24.4.600-606.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  Factors influencing the susceptibility of Candida albicans to the polyenoic antibiotics nystatin and amphotericin B.

Authors:  B Johnson; R J White; G M Williamson
Journal:  J Gen Microbiol       Date:  1978-02

2.  Fungistatic activity, uptake and incorporation of 5-fluorocytosine in Candida albicans, as influenced by pyrimidines and purines. I. Reversal experiments.

Authors:  A Polak; H J Scholer
Journal:  Pathol Microbiol (Basel)       Date:  1973

3.  The action of miconazole of the growth of Candida albicans.

Authors:  H Van Den Bossche; G Willemsens; J M Van Cutsem
Journal:  Sabouraudia       Date:  1975-03

4.  Miconazole-resistant Candida.

Authors:  R J Holt; A Azmi
Journal:  Lancet       Date:  1978-01-07       Impact factor: 79.321

Review 5.  Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy.

Authors:  J E Edwards; R I Lehrer; E R Stiehm; T J Fischer; L S Young
Journal:  Ann Intern Med       Date:  1978-07       Impact factor: 25.391

6.  Pathogenicity in mice of strains of Candida albicans with different in vitro sensitivity to 5-fluorocytosine.

Authors:  M Persson; B Winblad; S Anséhn; J Schönebeck
Journal:  Scand J Infect Dis       Date:  1978

7.  Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester.

Authors:  P D Hoeprich; A C Huston
Journal:  J Infect Dis       Date:  1976-10       Impact factor: 5.226

8.  Turbidimetric studies of growth inhibition of yeasts with three drugs: inquiry into inoculum-dependent susceptibility testing, time of onset of drug effect, and implications for current and newer methods.

Authors:  J N Galgiant; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

9.  Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size.

Authors:  J N Galgiani; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

10.  Disk agar diffusion susceptibility testing of yeasts.

Authors:  M A Saubolle; P D Hoeprich
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

View more
  30 in total

1.  Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests.

Authors:  A Espinel-Ingroff; C W Kish; T M Kerkering; R A Fromtling; K Bartizal; J N Galgiani; K Villareal; M A Pfaller; T Gerarden; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

2.  Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents.

Authors:  F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

3.  In vitro studies of activities of some antifungal agents against Candida albicans ATCC 10231 by the turbidimetric method.

Authors:  M T Blanco; C Pérez-Giraldo; J Blanco; F J Morán; C Hurtado; A C Gómez-García
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

4.  Persistent colonization of carbon dioxide incubators with Candida parapsilosis.

Authors:  G Schär; M Grehn; A von Graevenitz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-10       Impact factor: 3.267

Review 5.  Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome.

Authors:  M A Ghannoum; J H Rex; J N Galgiani
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

6.  Analysis of growth characteristics of filamentous fungi in different nutrient media.

Authors:  J Meletiadis; J F Meis; J W Mouton; P E Verweij
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 7.  In vitro and in vivo evaluation of antifungal agents.

Authors:  A Espinel-Ingroff; S Shadomy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

Review 8.  Azole resistance in Candida.

Authors:  D W Denning; G G Baily; S V Hood
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

Review 9.  Plasticity of Candida albicans Biofilms.

Authors:  David R Soll; Karla J Daniels
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-01       Impact factor: 11.056

10.  Effects of temperature on anti-Candida activities of antifungal antibiotics.

Authors:  F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.